Gordon Ens
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Surgery 4
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- Sheryl G. A. Gabram (1 shared paper)Daniel T. Engelman (1 shared paper)Lenworth M. Jacobs (1 shared paper)Joseph A. Church (1 shared paper)Robert W. Sugerman (1 shared paper)Jonathan C. Goldsmith (1 shared paper)Satyendra Giri (1 shared paper)James D. Otvos (1 shared paper)
- Journals
- The Journal of the Acoustical Society of America (2 papers)Journal of the American College of Cardiology (2 papers)The Pediatric Infectious Disease Journal (1 paper)Molecular Diagnosis & Therapy (1 paper)Atherosclerosis (1 paper)
- Partner nations
- United States
In The Last Decade
Gordon Ens
17 papers receiving 295 citations
Peers
Comparison fields: 5 of 64
- Internal Medicine 79
- Critical Care and Intensive Care Medicine 48
- Emergency Medicine 71
- Hematology 50
- Cardiology and Cardiovascular Medicine 69
Countries citing papers authored by Gordon Ens
This map shows the geographic impact of Gordon Ens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Ens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Ens more than expected).
Fields of papers citing papers by Gordon Ens
This network shows the impact of papers produced by Gordon Ens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Ens. The network helps show where Gordon Ens may publish in the future.
Co-authors
The 25 scholars most cited alongside Gordon Ens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 100 | |
| 2 | 1998 | 81 | |
| 3 | 1996 | 40 | |
| 4 | 2021 | 19 | |
| 5 | 2002 | 16 | |
| 6 | 2021 | 13 | |
| 7 | 1991 | 10 | |
| 8 | 2008 | 8 | |
| 9 | 1967 | 7 | |
| 10 | Resistance to activated protein C: a major cause of inherited thrombophilia. | 1997 | 4 |
| 11 | 1999 | 2 | |
| 12 | Abstract 15997: First Report of a Dose Dependent Effect of Statin Therapy on Urinary 11-dehydrothromboxane Br2 rLevels: A New Marker for Personalizing Statin Therapy | 2012 | 1 |
| 13 | 2012 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2005 | 1 | |
| 16 | 1977 | 1 | |
| 17 | 1978 | 1 |
About Gordon Ens
Gordon Ens is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Infectious Diseases, Pharmacology and Hematology, having authored 17 papers that have together received 306 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), COVID-19 Clinical Research Studies (3 papers), Inflammatory mediators and NSAID effects (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Hemophilia Treatment and Research (1 paper), Long-Term Effects of COVID-19 (1 paper) and Animal Nutrition and Physiology (1 paper). The work is most often cited by research in Internal Medicine (79 citations), Critical Care and Intensive Care Medicine (48 citations), Emergency Medicine (71 citations), Hematology (50 citations) and Cardiology and Cardiovascular Medicine (69 citations). Gordon Ens has collaborated with scholars based in United States. Frequent co-authors include Sheryl G. A. Gabram, Daniel T. Engelman, Lenworth M. Jacobs, Joseph A. Church, Robert W. Sugerman, Jonathan C. Goldsmith, Satyendra Giri, James D. Otvos, Alan H.B. Wu and Paul D. Thompson. Their work appears in journals such as The Journal of the Acoustical Society of America, Journal of the American College of Cardiology, The Pediatric Infectious Disease Journal, Molecular Diagnosis & Therapy and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.